Drogenscreening (Haar)
Inhalt
Interpretation
Allgemeines
Die Bestimmung umfasst folgende Analyten:
Monoacethylmorphin *)
MDMA (Ecstasy) *)
Tetrahydrocannabinol *)
Nordiazepam *)
MDA (Designerdroge) *)
Alprazolam *)
Oxazepam *)
7-Aminoflunitrazepam *)
Dihydrocodein *)
Methamphetamin *)
Lorazepam *)
Morphin *)
Diazepam *)
(Metabolit v. Heroin) *)
Cocain *)
Codein *)
(Metab.v.Flunitrazepam)*)
Methadon *)
(Metabolit v.Cocain) *)
Flunitrazepam *)
Amphetamine *)
Benzoylecgonin *)
Bromazepam *)
EDDP (Metab.v.Methadon *)
MDMA (Ecstasy) *)
Tetrahydrocannabinol *)
Nordiazepam *)
MDA (Designerdroge) *)
Alprazolam *)
Oxazepam *)
7-Aminoflunitrazepam *)
Dihydrocodein *)
Methamphetamin *)
Lorazepam *)
Morphin *)
Diazepam *)
(Metabolit v. Heroin) *)
Cocain *)
Codein *)
(Metab.v.Flunitrazepam)*)
Methadon *)
(Metabolit v.Cocain) *)
Flunitrazepam *)
Amphetamine *)
Benzoylecgonin *)
Bromazepam *)
EDDP (Metab.v.Methadon *)
Referenzbereiche
Geschlecht | Normwerte / pathologische Grenzen | |
|---|---|---|
Allgemein o. Männlich | MDMA (Ecstasy) *): Cut off: <0.10 ng/mg EDDP (Metab.v.Methadon *): Cut off: <0.10 ng/mg Bromazepam *): Cut off: <0.05 ng/mg Amphetamine *): Cut off: <0.10 ng/mg Diazepam *): Cut off: <0.05 ng/mg Flunitrazepam *): Cut off: <0.05 ng/mg Morphin *): Cut off: <0.10 ng/mg Dihydrocodein *): Cut off: <0.10 ng/mg Alprazolam *): Cut off: <0.05 ng/mg MDA (Designerdroge) *): Cut off: <0.10 ng/mg (Metab.v.Flunitrazepam)*): Cut off: <0.05 ng/mg (Metabolit v.Cocain) *): Cut off: <0.10 ng/mg Nordiazepam *): Cut off: <0.05 ng/mg Tetrahydrocannabinol *): Cut off: <0.02 ng/mg (Metabolit v. Heroin) *): Cut off: <0.10 ng/mg Cocain *): Cut off: <0.10 ng/mg Codein *): Cut off: <0.10 ng/mg Methadon *): Cut off: <0.10 ng/mg Lorazepam *): Cut off: <0.05 ng/mg Methamphetamin *): Cut off: <0.10 ng/mg Oxazepam *): Cut off: <0.05 ng/mg | |
Weiblich | ||
Kinder | ||
Ohne Angabe | ||
- Stand: 02.02.2023
